Sinopharm Group Co Stock Technical Analysis
| SHTDF Stock | USD 2.35 0.00 0.00% |
As of the 3rd of February, Sinopharm Group has the Risk Adjusted Performance of (0.07), coefficient of variation of (960.29), and Variance of 1.05. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sinopharm Group, as well as the relationship between them. Please validate Sinopharm Group market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Sinopharm Group is priced more or less accurately, providing market reflects its prevalent price of 2.35 per share. Please also confirm Sinopharm Group Co information ratio, which is currently at (0.16) to double-check the company can sustain itself at a future point.
Sinopharm Group Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sinopharm, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SinopharmSinopharm |
Sinopharm Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinopharm Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinopharm Group.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Sinopharm Group on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Sinopharm Group Co or generate 0.0% return on investment in Sinopharm Group over 90 days. Sinopharm Group is related to or competes with Shanghai Pharmaceuticals, Matsumotokiyoshi, Sysmex Corp, Sonic Healthcare, Sonic Healthcare, Guangzhou Baiyunshan, and ConvaTec Group. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and heal... More
Sinopharm Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinopharm Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinopharm Group Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 8.48 |
Sinopharm Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinopharm Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinopharm Group's standard deviation. In reality, there are many statistical measures that can use Sinopharm Group historical prices to predict the future Sinopharm Group's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | 0.4538 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinopharm Group's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sinopharm Group February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 0.4638 | |||
| Mean Deviation | 0.3609 | |||
| Coefficient Of Variation | (960.29) | |||
| Standard Deviation | 1.02 | |||
| Variance | 1.05 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | 0.4538 | |||
| Maximum Drawdown | 8.48 | |||
| Skewness | (2.85) | |||
| Kurtosis | 16.58 |
Sinopharm Group Backtested Returns
Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Sinopharm Group Co exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sinopharm Group's Risk Adjusted Performance of (0.07), variance of 1.05, and Coefficient Of Variation of (960.29) to confirm the risk estimate we provide. The entity has a beta of -0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sinopharm Group are expected to decrease at a much lower rate. During the bear market, Sinopharm Group is likely to outperform the market. At this point, Sinopharm Group has a negative expected return of -0.12%. Please make sure to validate Sinopharm Group's jensen alpha and rate of daily change , to decide if Sinopharm Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Sinopharm Group Co has no correlation between past and present. Overlapping area represents the amount of predictability between Sinopharm Group time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinopharm Group price movement. The serial correlation of 0.0 indicates that just 0.0% of current Sinopharm Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Sinopharm Group technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Sinopharm Group Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Sinopharm Group across different markets.
About Sinopharm Group Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sinopharm Group Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sinopharm Group Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sinopharm Group price pattern first instead of the macroeconomic environment surrounding Sinopharm Group. By analyzing Sinopharm Group's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sinopharm Group's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sinopharm Group specific price patterns or momentum indicators. Please read more on our technical analysis page.
Sinopharm Group February 3, 2026 Technical Indicators
Most technical analysis of Sinopharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sinopharm from various momentum indicators to cycle indicators. When you analyze Sinopharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 0.4638 | |||
| Mean Deviation | 0.3609 | |||
| Coefficient Of Variation | (960.29) | |||
| Standard Deviation | 1.02 | |||
| Variance | 1.05 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | 0.4538 | |||
| Maximum Drawdown | 8.48 | |||
| Skewness | (2.85) | |||
| Kurtosis | 16.58 |
Sinopharm Group February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Sinopharm stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 2.35 | ||
| Day Typical Price | 2.35 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Sinopharm Pink Sheet analysis
When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |